Use of Roche’s haemophilia A therapy Hemlibra expanded in the US

5th October 2018 Uncategorised 0

Roche’s Hemlibra has been approved in the US for routine prophylaxis of bleeding episodes patients with haemophilia A without factor VIII inhibitors.

More: Use of Roche’s haemophilia A therapy Hemlibra expanded in the US
Source: News